Subakut Sklerozan Panensefalit ve Yavaş Virüs Enfeksiyonları

World Health Organization. Progress towards regional measles elimination—worldwide, 2000–2017. Weekly epidemiological record.2018, 93, 649–660. Downloaded from https://apps.who.int/iris/bitstream/handle/10665/276217/WER9348.pdf?ua=1&ua=1.Accessed on 28 March, 2019.

World Health Organization. Weekly epidemiological record. No. 2,2006, 81, 13–20 http://www.who.int/vaccine_safety/committee/Reports/wer8102.pdf?ua=1. Accessed on 28 March, 2019.

Guler S, Kucukkoc M, Iscan A. Prognosis and demographic characteristics of SSPE patients in Istanbul, Turkey. Brain Dev.2015;37(6):612‐617.

Wendorf KA, Winter K, Zipprich J, et al. Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated. Clin Infect Dis. 2017;65(2):226‐232.

Bellini WJ, Rota JS, Lowe LE, et al. Subacute sclerosingpanencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis. 2005;192(10):1686‐1693.

Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V, Billeter MA.Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell. 1988;55(2):255‐265.

Karakas‐Celik S, Piskin IE, Keni MF, Calik M, Iscan A, Dursun A. May TLR4 Asp299Gly and IL17 His161Arg polymorphism be associated with progression of primary measles infection to subacute sclerosing panencephalitis? Gene. 2014;547(2):186‐190.

Dundar NO, Gencpinar P, Sallakci N, et al. Interleukin‐12 (‐1188) A/C and interferon‐? (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol. 2016;22(5): 661‐665.

Garg, R. K., Mahadevan, A., Malhotra, H. S., Rizvi, I., Kumar, N., & Uniyal, R. (2019). Subacute sclerosing panencephalitis. Reviews in medical virology, 29(5), e2058.

Dundar, N. O., et al. "Subacute sclerosing panencephalitis case presenting with cortical blindness: early diagnosis with MRI and MR spectroscopy." Clinical Neuroradiology 24 (2014): 185-188.

Khare S, Kumari S, Sehgal S. Sero‐epidemiology of subacute sclerosing panencephalitis in Delhi. Indian J Med Res. 1990;91:94‐97.

Manayani DJ, Abraham M, Gnanamuthu C, Solomon T, Alexander M, Sridharan G. SSPE—the continuing challenge: a study based on serological evidence from a tertiary care centre in India. Indian J Med Microbiol. 2002;20(1):16‐18.

Government of Canada. Viral Exanthemata & STDs—MeaslesMumps and Rubella Unit. Subacute sclerosing panencephalitis (SSPE)diagnosis. https://cnphi.canada.ca/gts/reference‐diagnostic‐test/5004?labId=1016. Accessed on 28 March, 2019.

Arhan, E., Akbaş, Y., Serdaroğlu, A., Direk, M. C., Okuyaz, Ç., Havalı, C., & Aydın, K. (2021). Magnetic resonance imaging patterns of subacute sclerosing panencephalitis may mimic metabolic disorders: clinical, electroencephalographic and imaging features of six cases. Acta Neurologica Belgica, 121, 955-965.

Chowdhury, Y. S., Saha, N. C., Yusuf, M. A., Islam, A., Hoque, S. A., Chowdhury, R. N., & Hussain, M. E. (2017). Role of Routine Benzodiazepin in Eliciting Classical Electroencephalogram (EEG) Response in Suspected Sub-Acute Sclerosing Panencephalitis (SSPE) Cases. World Journal of Neuroscience, 7(01), 32.

Saini AG, Sankhyan N, Padmanabh H, Sahu JK, Vyas S, Singhi P. Subacute sclerosing panencephalitis presenting as acute cerebellar ataxia and brain stem hyperintensities. Eur J Paediatr Neurol. 2016;20(3):435‐438.

Häusler M, Aksoy A, Alber M, et al. A multinational survey on actual diagnostics and treatment of subacute sclerosing panencephalitis. Neuropediatrics. 2015; 46:377‐384.

Ravikumar S, Crawford JR. Role of carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: a case report and review of the literature. Case Rep Neurol Med. 2013:327647

Watanabe, Masahiro, et al. "A novel peptide derived from the fusion protein heptad repeat inhibits replication of subacute sclerosing panencephalitis virus in vitro and in vivo." PLoS One 11.9 (2016): e0162823.

Nafe, Reinhold, Christophe T. Arendt, and Elke Hattingen. "Human prion diseases and the prion protein–what is the current state of knowledge?." Translational Neuroscience 14.1 (2023): 20220315.

Sun, Y. et al. Incidence of and mortality due to human prion diseases in Taiwan: a prospective 20-year nationwide surveillance study from 1998 to 2017. Clin. Epidemiol.12, 1073–1081 (2020).

Hermann, Peter, et al. "Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease." The Lancet Neurology 20.3 (2021): 235-246.

Zerr, Inga, et al. "Creutzfeldt–Jakob disease and other prion diseases." Nature Reviews Disease Primers 10.1 (2024): 14.

Chen, Zhongyun, et al. "Genetic and pathological features encipher the phenotypic heterogeneity of Gerstmann-Sträussler-Scheinker disease." Neurobiology of Disease 195 (2024): 106497.

Stephen, Christopher D., et al. "Gerstmann‐Sträussler‐Scheinker Disease Presenting as Late‐Onset Slowly Progressive Spinocerebellar Ataxia, and Comparative Case Series with Neuropathology." Movement Disorders Clinical Practice 11.4 (2024): 411-423.

Zou, Xianlin, Louis J. Ptáček, and Ying-Hui Fu. "The Genetics of Human Sleep and Sleep Disorders." Annual Review of Genomics and Human Genetics 25 (2024).

Llorens, Franc, et al. "Fatal familial insomnia: Clinical aspects and molecular alterations." Current neurology and neuroscience reports 17 (2017): 1-7.

Kothekar, Himanshu, and Kirti Chaudhary. "Kuru disease: bridging the gap between prion biology and human health." Cureus 16.1 (2024).